Medicon Hellas SA 

€2.5
2
-€0.02-0.79% Friday 11:37

統計

當日最高
2.52
當日最低
2.41
52週最高
3.72
52週最低
2.23
成交量
8,003
平均成交量
2,554
市值
16.44M
市盈率
21.75
股息收益率
2.4%
股息
0.06

即將到來

股息

2.4%股息收益率
10年增長
N/A
5年增長率
N/A
3年增長率
N/A
1年增長率
N/A

收益

25Jun預期
Q3 2017
Q1 2024
0.29
0.62
0.96
1.29
預期每股收益
N/A
實際每股收益
N/A

人們還關注

此列表基於在 Stock Events 上關注 MEDIC.AT 的人的關注列表。這不是投資建議。

競爭者

這個列表是基於最近市場事件的分析。這不是投資建議。

關於

Medicon Hellas S.A. operates in the diagnostics industry. The company offers instruments, tests, and procedures for public and private hospitals, primary care centers, diagnostic centers, and private laboratories in Greece and internationally. The company imports and distributes analytical workstations for chemistry, immunochemistry and hematology labs, intensive care units, and point-of-care systems under the MLR name. It also produces instrument-specific and barcoded vial reagents for various analyzers, such as specific protein and hematology, as well as clinical chemistry reagents comprising control and calibration materials, and tests. In addition, the company engages in the production of cosmetic and skin care products under the Miss Beaute brand name. Further, it develops and sells software for laboratory and medical applications, and supplies IT systems to healthcare providers. Additionally, the company remanufactures and resells chemistry, hematology, blood gas, and immunochemistry analyzers; and provides contract remanufacturing and diagnostics laboratory services. Medicon Hellas S.A. was founded in 1988 and is headquartered in Gerakas, Greece.
Show more...
首席執行官
Mr. Dimotsantos S. Spyridon
員工
180
國家
Greece
ISIN
GRS424003002

上市公司